HighMPNN: A Graph Neural Network Approach for Structure-Constrained Cyclic Peptide Sequence Design

19 May 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Cyclic peptides become attractive therapeutic candidates due to their diverse biological activities. However, existing deep learning-based sequence design models, such as ProteinMPNN, are primarily optimized using cross-entropy loss and often overlook the unique topological constraints of cyclic peptides. This limits their ability to generate structurally accurate and foldable sequences. To address this challenge, we propose HighMPNN, a graph neural network model that builds upon ProteinMPNN by incorporating a structure prediction module and integrating cross-entropy loss with Frame Aligned Point Error (FAPE) loss. This dual-loss strategy enables the simultaneous optimization of sequence generation and structural fidelity, making HighMPNN better suited for cyclic peptide design. HighMPNN demonstrates superior performance in both sequence recovery and structural consistency compared to baseline models, particularly for short cyclic peptides and specific secondary structures. In summary, HighMPNN enables the design of sequences that closely resemble the native structures, thereby accelerating the discovery of high-quality cyclic peptides and advancing peptide-based drug development.

Keywords

cyclic peptide
sequence design
GNN
deep learning

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.